Charles Schwab’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.97M | Sell |
447,359
-12,086
| -3% | -$65.3K | ﹤0.01% | 2725 |
|
|
2025
Q4 | $2.92M | Sell |
459,445
-111,410
| -20% | -$775K | ﹤0.01% | 2640 |
|
|
2025
Q3 | $5.33M | Buy |
570,855
+414,733
| +266% | +$4.19M | ﹤0.01% | 2412 |
|
|
2025
Q2 | $2.25M | Buy |
156,122
+11,499
| +8% | +$114K | ﹤0.01% | 2628 |
|
|
2025
Q1 | $998K | Buy |
144,623
+2
| +0% | +$13 | ﹤0.01% | 2843 |
|
|
2024
Q4 | $767K | Buy |
144,621
+4,452
| +3% | +$24.4K | ﹤0.01% | 2999 |
|
|
2024
Q3 | $512K | Hold |
140,169
| – | – | ﹤0.01% | 3153 |
|
|
2024
Q2 | $383K | Buy |
140,169
+115,502
| +468% | +$386K | ﹤0.01% | 3296 |
|
|
2024
Q1 | $85.8K | Hold |
24,667
| – | – | ﹤0.01% | 3320 |
|
|
2023
Q4 | $35.3K | Hold |
24,667
| – | – | ﹤0.01% | 3436 |
|
|
2023
Q3 | $36K | Hold |
24,667
| – | – | ﹤0.01% | 3439 |
|
|
2023
Q2 | $38.7K | Hold |
24,667
| – | – | ﹤0.01% | 3457 |
|
|
2023
Q1 | $37.7K | Hold |
24,667
| – | – | ﹤0.01% | 3396 |
|
|
2022
Q4 | $41.4K | Hold |
24,667
| – | – | ﹤0.01% | 3396 |
|
|
2022
Q3 | $31K | Hold |
24,667
| – | – | ﹤0.01% | 3429 |
|
|
2022
Q2 | $42K | Sell |
24,667
-102,969
| -81% | -$201K | ﹤0.01% | 3420 |
|
|
2022
Q1 | $314K | Hold |
127,636
| – | – | ﹤0.01% | 3207 |
|
|
2021
Q4 | $478K | Buy |
127,636
+4,824
| +4% | +$26K | ﹤0.01% | 3161 |
|
|
2021
Q3 | $771K | Buy |
122,812
+5,362
| +5% | +$44.2K | ﹤0.01% | 2976 |
|
|
2021
Q2 | $1.16M | Buy |
117,450
+10,986
| +10% | +$95.8K | ﹤0.01% | 2874 |
|
|
2021
Q1 | $995K | Buy |
106,464
+5,391
| +5% | +$42.7K | ﹤0.01% | 2863 |
|
|
2020
Q4 | $486K | Buy |
101,073
+4,905
| +5% | +$23.9K | ﹤0.01% | 3004 |
|
|
2020
Q3 | $386K | Sell |
96,168
-4,438
| -4% | -$21.4K | ﹤0.01% | 2957 |
|
|
2020
Q2 | $462K | Buy |
100,606
+2,673
| +3% | +$12K | ﹤0.01% | 2866 |
|
|
2020
Q1 | $320K | Sell |
97,933
-4,508
| -4% | -$17.3K | ﹤0.01% | 2869 |
|
|
2019
Q4 | $442K | Buy |
102,441
+5,177
| +5% | +$18.4K | ﹤0.01% | 2866 |
|
|
2019
Q3 | $383K | Buy |
97,264
+5,894
| +6% | +$25.1K | ﹤0.01% | 2903 |
|
|
2019
Q2 | $425K | Buy |
91,370
+6,880
| +8% | +$29.4K | ﹤0.01% | 2885 |
|
|
2019
Q1 | $355K | Buy |
84,490
+12,690
| +18% | +$45.8K | ﹤0.01% | 2889 |
|
|
2018
Q4 | $247K | Hold |
71,800
| – | – | ﹤0.01% | 2988 |
|
|
2018
Q3 | $309K | Hold |
71,800
| – | – | ﹤0.01% | 2998 |
|
|
2018
Q2 | $267K | Buy |
+71,800
| New | +$273K | ﹤0.01% | 3010 |
|
|
2017
Q2 | – | Sell |
-44,800
| Closed | -$121K | – | 3145 |
|
|
2017
Q1 | $121K | Hold |
44,800
| – | – | ﹤0.01% | 2995 |
|
|
2016
Q4 | $149K | Hold |
44,800
| – | – | ﹤0.01% | 3008 |
|
|
2016
Q3 | $134K | Hold |
44,800
| – | – | ﹤0.01% | 2988 |
|
|
2016
Q2 | $186K | Buy |
+44,800
| New | +$212K | ﹤0.01% | 2964 |
|
Other funds holding NAGE
SW
VCM
TCM
